Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerular Nephritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02682407
What this trial is testing

Safety Study of IgAN, LN, MN, & C3 Glomerulopathy Including Dense Deposit Disease Treated With OMS721

Who this might be right for
IgANLNMN+1 more
Omeros Corporation 31
Testing effectiveness (Phase 2)Looking for participantsNCT07268638
What this trial is testing

Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Segmental Glomerulosclerosis
Akebia Therapeutics 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07659704
What this trial is testing

CD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Systemic
University of Sao Paulo 16
Large-scale testing (Phase 3)UnknownNCT03298698
What this trial is testing

Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic SyndromeMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Radboud University Medical Center 40
Not applicableNot Yet RecruitingNCT07481084
What this trial is testing

IgA Nephropathy Insights From Treatment Experience Among Patients Receiving Iptacopan and/or Atrasentan Using Primary Data Collection

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 80
Post-approval studies (Phase 4)Ended earlyNCT02226341
What this trial is testing

ACTHar in the Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Columbia University 8
Large-scale testing (Phase 3)Study completedNCT05534919
What this trial is testing

Efficacy and Safety in Chinese Patients with Immunoglobulin a Nephropathy (IgAN) Who Have Completed Study Nef-301

Who this might be right for
Primary Immunoglobulin a Nephropathy (IgAN)
Everest Medicines (Singapore) Pte. Ltd. 21
Early research (Phase 1)Study completedNCT01221181
What this trial is testing

Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy

Who this might be right for
Dense Deposit DiseaseMembranoproliferative Glomerulonephritis
Columbia University 6
Post-approval studies (Phase 4)UnknownNCT05916781
What this trial is testing

Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus ErythematosusLupus Nephritis
Chinese SLE Treatment And Research Group 220
Not applicableLooking for participantsNCT06527872
What this trial is testing

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

Who this might be right for
Lupus Nephritis
GlaxoSmithKline 300
Testing effectiveness (Phase 2)Looking for participantsNCT07038382
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)
Shanghai Henlius Biotech 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05517980
What this trial is testing

Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of KP104 to Treat Glomerulonephritis

Who this might be right for
Glomerulonephritis
Kira Pharmacenticals (US), LLC. 52
Testing effectiveness (Phase 2)Ended earlyNCT05162066
What this trial is testing

Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN)

Who this might be right for
Complement 3 GlomerulopathyImmunoglobulin A NephropathyMembranous Nephropathy
BioCryst Pharmaceuticals 2
Not applicableUnknownNCT01126931
What this trial is testing

Wormwood in Chronic Progressive Disorders With Reduced Appetite

Who this might be right for
Cancer
University Hospital Freiburg 300
Not applicableStudy completedNCT01931644
What this trial is testing

At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions

Who this might be right for
All Diagnosed Health ConditionsADD/ADHDAlopecia Areata+58 more
Sanguine Biosciences 17,667
Not applicableLooking for participantsNCT07666711
What this trial is testing

Biomarker Development for Autoimmune Disorders Involving the Kidneys

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Oslo University Hospital 500
Testing effectiveness (Phase 2)WithdrawnNCT04883619
What this trial is testing

Nipocalimab in Adult Participants With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Janssen Research & Development, LLC
Not applicableLooking for participantsNCT05650619
What this trial is testing

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseFSGS+1 more
University of Michigan 300
Not applicableStudy completedNCT06767592
What this trial is testing

Probiotics in IgA Nephropathy

Who this might be right for
IgA Nephropathy
University of Leicester 18
Not applicableStudy completedNCT04428398
What this trial is testing

Urinary T Lymphocytes Predict Renal Flares in Patients With Inactive ANCA-associated Glomerulonephritis

Who this might be right for
Glomerulonephritis Acute
Charite University, Berlin, Germany 100
Next Page